Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{ea54577ed1154dec9f0d2d67a4ac3389,
title = "Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients",
abstract = "Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a {"}long COVID{"} syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants received a digital questionnaire on demographics and COVID-19-related symptoms. Persistent symptoms: symptoms > 4 weeks (in sensitivity analyses > 12 weeks). We included 445 participants, of whom 34% were asymptomatic. Most common acute symptoms were fatigue, headache, and sneezing, while fatigue and reduced smell and taste were most severe. Persistent symptoms, most commonly fatigue and memory and concentration difficulties, were reported by 36% of 198 symptomatic participants with follow-up > 4 weeks. Risk factors for persistent symptoms included female sex (women 44% vs. men 24%, odds ratio 2.7, 95% CI 1.4-5.1, p = 0.003) and BMI (odds ratio 1.1, 95% CI 1.0-1.2, p = 0.001). In conclusion, among non-hospitalized PCR-confirmed COVID-19 patients one third were asymptomatic while one third of symptomatic participants had persistent symptoms illustrating the heterogeneity of disease presentation. These findings should be considered in health care planning and policy making related to COVID-19.",
keywords = "Acute Disease, Adult, Body Mass Index, COVID-19/complications, Cohort Studies, Female, Humans, Male, Middle Aged, Polymerase Chain Reaction, Risk Factors, Sex Factors, Surveys and Questionnaires",
author = "Sofie Bliddal and Karina Banasik and Pedersen, {Ole Birger} and Janna Nissen and Lisa Cantwell and Michael Schwinn and Morten Tulstrup and David Westergaard and Henrik Ullum and S{\o}ren Brunak and Niels Tommerup and Bjarke Feenstra and Frank Geller and Ostrowski, {Sisse Rye} and Kirsten Gr{\o}nb{\ae}k and Nielsen, {Claus Henrik} and Nielsen, {Susanne Dam} and Ulla Feldt-Rasmussen",
year = "2021",
month = jun,
day = "23",
doi = "10.1038/s41598-021-92045-x",
language = "English",
volume = "11",
pages = "13153",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

RIS

TY - JOUR

T1 - Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients

AU - Bliddal, Sofie

AU - Banasik, Karina

AU - Pedersen, Ole Birger

AU - Nissen, Janna

AU - Cantwell, Lisa

AU - Schwinn, Michael

AU - Tulstrup, Morten

AU - Westergaard, David

AU - Ullum, Henrik

AU - Brunak, Søren

AU - Tommerup, Niels

AU - Feenstra, Bjarke

AU - Geller, Frank

AU - Ostrowski, Sisse Rye

AU - Grønbæk, Kirsten

AU - Nielsen, Claus Henrik

AU - Nielsen, Susanne Dam

AU - Feldt-Rasmussen, Ulla

PY - 2021/6/23

Y1 - 2021/6/23

N2 - Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a "long COVID" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants received a digital questionnaire on demographics and COVID-19-related symptoms. Persistent symptoms: symptoms > 4 weeks (in sensitivity analyses > 12 weeks). We included 445 participants, of whom 34% were asymptomatic. Most common acute symptoms were fatigue, headache, and sneezing, while fatigue and reduced smell and taste were most severe. Persistent symptoms, most commonly fatigue and memory and concentration difficulties, were reported by 36% of 198 symptomatic participants with follow-up > 4 weeks. Risk factors for persistent symptoms included female sex (women 44% vs. men 24%, odds ratio 2.7, 95% CI 1.4-5.1, p = 0.003) and BMI (odds ratio 1.1, 95% CI 1.0-1.2, p = 0.001). In conclusion, among non-hospitalized PCR-confirmed COVID-19 patients one third were asymptomatic while one third of symptomatic participants had persistent symptoms illustrating the heterogeneity of disease presentation. These findings should be considered in health care planning and policy making related to COVID-19.

AB - Reports of persistent symptoms after hospitalization with COVID-19 have raised concern of a "long COVID" syndrome. This study aimed at determining the prevalence of and risk factors for acute and persistent symptoms in non-hospitalized patients with polymerase chain reaction (PCR) confirmed COVID-19. We conducted a cohort study of non-hospitalized participants identified via the Danish Civil Registration System with a SARS-CoV-2-positive PCR-test and available biobank samples. Participants received a digital questionnaire on demographics and COVID-19-related symptoms. Persistent symptoms: symptoms > 4 weeks (in sensitivity analyses > 12 weeks). We included 445 participants, of whom 34% were asymptomatic. Most common acute symptoms were fatigue, headache, and sneezing, while fatigue and reduced smell and taste were most severe. Persistent symptoms, most commonly fatigue and memory and concentration difficulties, were reported by 36% of 198 symptomatic participants with follow-up > 4 weeks. Risk factors for persistent symptoms included female sex (women 44% vs. men 24%, odds ratio 2.7, 95% CI 1.4-5.1, p = 0.003) and BMI (odds ratio 1.1, 95% CI 1.0-1.2, p = 0.001). In conclusion, among non-hospitalized PCR-confirmed COVID-19 patients one third were asymptomatic while one third of symptomatic participants had persistent symptoms illustrating the heterogeneity of disease presentation. These findings should be considered in health care planning and policy making related to COVID-19.

KW - Acute Disease

KW - Adult

KW - Body Mass Index

KW - COVID-19/complications

KW - Cohort Studies

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Polymerase Chain Reaction

KW - Risk Factors

KW - Sex Factors

KW - Surveys and Questionnaires

UR - http://www.scopus.com/inward/record.url?scp=85108842386&partnerID=8YFLogxK

U2 - 10.1038/s41598-021-92045-x

DO - 10.1038/s41598-021-92045-x

M3 - Journal article

C2 - 34162913

VL - 11

SP - 13153

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 13153

ER -

ID: 66429695